Related Experiment Video
Updated: Jul 8, 2025

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
Published on: October 9, 2016
The qMini assay identifies an overlooked class of splice variants
Bin Guan1, Chelsea Bender1, Madhulatha Pantrangi2
1Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD.
Abstract:
Splice variants are known to cause diseases by utilizing alternative splice sites, potentially resulting in protein truncation or mRNA degradation by nonsense-mediated decay. Splice variants are verified when altered mature mRNA sequences are identified in RNA analyses or minigene assays. Using a quantitative minigene assay, qMini, we uncovered a previously overlooked class of disease-associated splice variants that did not alter mRNA sequence but decreased mature mRNA level, suggesting a potentially new pathogenic mechanism.
Insights
Disease-causing splice variants typically alter mRNA sequences. Our study identified a new class of splice variants that decrease mature mRNA levels without changing the sequence, revealing a novel disease mechanism.
Area of Science:
- Molecular Biology
- Genetics
- Disease Mechanisms
Background:
- Alternative splicing can lead to disease by altering mature mRNA sequences.
- Established methods for identifying splice variants include RNA analyses and minigene assays.
- Known consequences of altered splicing include protein truncation and nonsense-mediated mRNA decay.
Conclusions:
- Splice variants can contribute to disease through mechanisms beyond sequence alteration.
- Decreased mature mRNA levels, independent of sequence changes, represent a potential pathogenic pathway.
- The qMini assay is effective in identifying these previously overlooked splice variants.
Related Concept Videos
Alternative RNA Splicing
RNA Splicing
Pre-mRNA Processing: RNA Splicing

